Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period

Cha, 2005, Molecular mechanisms in hepatocellular carcinoma development, Best Pract Res Clin Gastroenterol, 19, 25, 10.1016/j.bpg.2004.11.005 Ganem, 2004, Hepatitis B virus infection—natural history and clinical consequences, N Engl J Med, 350, 1118, 10.1056/NEJMra031087 Goldstein, 2005, A mathematical model to estimate global hepatitis B disease burden and vaccination impact, Int J Epidemiol, 34, 1329, 10.1093/ije/dyi206 Lok, 2004, Prevention of hepatitis B virus-related hepatocellular carcinoma, Gastroenterology, 127, S303, 10.1053/j.gastro.2004.09.045 Wang, 2001, Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China, Cancer Epidemiol Biomarkers Prev, 10, 143 Shi, 2005, A meta-analysis of case–control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China, Br J Cancer, 92, 607, 10.1038/sj.bjc.6602333 Chen, 2010, Analysis of liver cancer mortality in the national retrospective sampling survey of death causes in China, 2004–2005, Chin J Prev Med, 44, 383 Bosch, 2002, The epidemiology of primary liver cancer: global epidemiology, 1 Luo, 2005, Risk factors for primary liver carcinoma in Chinese population, World J Gastroenterol, 11, 4431, 10.3748/wjg.v11.i28.4431 Xin, 2006, Hepatitis B virus, hepatitis C virus infection and primary liver cancer research, Chin J Clin Hepatol, 22, 64 Nguyen, 2009, Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden, J Viral Hepat, 16, 453, 10.1111/j.1365-2893.2009.01117.x Lavanchy, 2005, Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention, J Clin Virol, 34, S1, 10.1016/S1386-6532(05)00384-7 1992, Global Advisory Group, Weekly Epidemiol Rec, 67, 11 World Health Organization. Global immunization 1989–2010, 3rd dose of hepatitis B coverage in infants. Geneva: WHO; 2010. Available at: http://www.who.int/immunization_monitoring/diseases/HepB_coverage.jpg (accessed November 2011). World Health Organization Vaccines and Biologicals. WHO vaccine preventable disease monitoring system: 2009 global summary (data up to 2008). Geneva: WHO; 2009. Available at: http://whqlibdoc.who.int/hq/2009/WHO_IVB_2009_eng.pdf (accessed July 27, 2011). Chen, 2009, Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B, J Hepatol, 50, 805, 10.1016/j.jhep.2009.01.002 Zhuang, 2004, Hepatitis B vaccination in China, Basic Med Sci Clin, 24, 136 2005, The guideline of prevention and treatment for chronic hepatitis B, Chin J Hepatol, 13, 881 2007, Progress in hepatitis B prevention through universal infant vaccination—China, 1997–2006, MMWR Morb Mortal Wkly Rep, 56, 441 Yao, 2000, Investigation on immunization coverage rate and immune effect of hepatitis B vaccine among newborns in Zhejiang Province, Chin J Vaccines Immunization, 6, 132 Liu, 2000, Certain question discussion of hepatitis B vaccine inoculation, China Public Health, 16, 73 Xia, 1996, Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992, Int Hepatol Comm, 5, 62, 10.1016/S0928-4346(96)82012-3 Liang, 2005, A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3 years old, Chin J Epidemiol, 26, 655 Zhou, 2005, Public place jobholders hepatitis B virus infection and vaccine inoculation investigation, Modern Prev Med, 32, 1683 Tian, 2007, Infective status of HBV among population after 19 years immunization vaccine, Chin J Vaccines Immunization, 13, 4 Wu, 2005, Serological study on status of hepatitis B virus infection and carry in vaccinated population: a historical comparison, Chin J Vaccines Immunization, 11, 276 Liang, 2009, Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination, Vaccine, 27, 6550, 10.1016/j.vaccine.2009.08.048 Dai, 1996 Luo, 2003, The analysis of serological immune effect after HB vaccine being brought into the expanded program on immunization for ten years in Guangdong province, Chin J Vaccines Immunization, 9, 293 Ma, 2002, A 14-year survey for hepatitis B vaccine immune efficacy in newborns in rural area after universal immunization, Chin J Vaccines Immunization, 8, 181 Lei, 2006, Serological epidemiology of HBsAg and Anti-HBs for children in Zhujiang delta area of Guangdong Province, Chin J Vaccines Immunization, 12, 112 Yu, 2005, Studies and analysis on immunization coverage rate of hepatitis B (HB) vaccine and the HBsAg carrier rate of children below 3 years old and incidence rate for the past ten years in Wuhan city, Chin J Vaccines Immunization, 11, 117 Liang, 2009, Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China, J Infect Dis, 200, 39, 10.1086/599332 Yao, 1996, Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China, Gut, 38, S39, 10.1136/gut.38.Suppl_2.S39 Chen, 2006, Seroepidemiological study on viral hepatitis B of the eastern, middle, and western areas in China, Chin J Vaccines Immunization, 12, 246 Shen, 2011, Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme, Epidemiol Infect, 139, 1159, 10.1017/S0950268810002827 Blumberg, 1997, Hepatitis B virus, the vaccine, and the control of primary cancer of the liver, Proc Natl Acad Sci U S A, 94, 7121, 10.1073/pnas.94.14.7121 1983, A WHO meeting, Bull World Health Organ, 61, 731 Lee, 1998, Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea, Int J Epidemiol, 27, 316, 10.1093/ije/27.2.316 Chang, 1997, Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group, N Engl J Med, 336, 1855, 10.1056/NEJM199706263362602 Chang, 2009, Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study, J Natl Cancer Inst, 101, 1348, 10.1093/jnci/djp288 Stevens, 1975, Vertical transmission of hepatitis B antigen in Taiwan, N Engl J Med, 292, 771, 10.1056/NEJM197504102921503 Beasley, 1983, Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine, Lancet, 2, 1099, 10.1016/S0140-6736(83)90624-4 Lin, 1991, Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure, Vaccine, 9, 457, 10.1016/0264-410X(91)90135-S Ngui, 1998, Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors, Clin Infect Dis, 27, 100, 10.1086/514610 Lee, 1986, Prevention of maternal–infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA, Hepatology, 6, 369, 10.1002/hep.1840060306 Ip, 1989, Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA, Lancet, 1, 406, 10.1016/S0140-6736(89)90003-2 Burk, 1994, Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load, J Infect Dis, 170, 1418, 10.1093/infdis/170.6.1418 del Canho, 1994, Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates, J Hepatol, 20, 483, 10.1016/S0168-8278(05)80494-5 Liu, 2009, Influence of HBV gene heterogeneity on the failure of immunization with HBV vaccines in eastern China, Arch Virol, 154, 437, 10.1007/s00705-009-0315-y Deng, 2000, Relationship between maternal HBsAg, HBeAg titers and hepatitis B vaccine failure in infants born to HBV carrier mothers, Chin J Infect Dis, 18, 232 Wang, 2003, Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies, J Med Virol, 71, 360, 10.1002/jmv.10493 Song, 2007, Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus, Eur J Pediatr, 166, 813, 10.1007/s00431-006-0327-5 Kang, 2008, Comparison of the seroconversion rate after primary hepatitis B vaccination and after revaccination of non-responders in full-term infants according to mother's HBsAg seropositivity, Korean J Pediatr, 51, 1165, 10.3345/kjp.2008.51.11.1165 Carman, 1990, Vaccine-induced escape mutant of hepatitis B virus, Lancet, 336, 325, 10.1016/0140-6736(90)91874-A Hsu, 1997, Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis, Hepatology, 26, 786, 10.1002/hep.510260336 Francois, 2001, Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?, Vaccine, 19, 3799, 10.1016/S0264-410X(01)00108-6 Hu, 2005, Detection of mutants of the ‘a’ determinant region of hepatitis B surface antigen S gene among Wuhan childhood patients, Chin J Hepatol, 13, 594 Wang, 2009, The relationship between hepatitis B virus S gene variation, genetype and immunoprophylaxis failure to intrauterine infection of hepatitis B virus, Chin J Infect Dis, 27, 114 Oon, 1995, Molecular epidemiology of hepatitis B virus vaccine variants in Singapore, Vaccine, 13, 699, 10.1016/0264-410X(94)00080-7 Ngui, 1997, Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales, J Infect Dis, 176, 1360, 10.1086/514133 Nainan, 2002, Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection, J Med Virol, 68, 319, 10.1002/jmv.10206 Kim, 2005, The incidence rate of hepatitis B virus surface gene variants in Korean children with immunoprophylaxis failure of perinatal infection, Korean J Hepatol, 11, 320 Ogata, 1999, Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus, Hepatology, 30, 779, 10.1002/hep.510300309 Cui, 2007, Analysis on new born hepatitis B immunization coverage and pregnant women hospital delivery rate in different region, Chin J Vaccines Immunization, 13, 1 Kao, 2002, Global control of hepatitis B virus infection, Lancet Infect Dis, 2, 395, 10.1016/S1473-3099(02)00315-8 Hoofnagle, 2007, Management of hepatitis B: summary of a clinical research workshop, Hepatology, 45, 1056, 10.1002/hep.21627 Margolis, 1998, Hepatitis B virus infection, Bull World Health Organ, 76, 152 Xu, 2006, A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG, World J Gastroenterol, 12, 3434, 10.3748/wjg.v12.i21.3434 Li, 2008, The clinical observation of pregnant to inject HBIG in the later period and the newborn to inject HBIG and HB vaccine blocking the HBV maternal infant transmission, Maternal and Child Health Care of China, 23, 2611 Kabir, 2006, Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone, Hepatol Res, 36, 265, 10.1016/j.hepres.2006.08.001